Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

被引：0

作者：

Demirci, Umut ^{[1
]}

Gokmen, Erhan ^{[2
]}

Eralp, Yesim ^{[3
]}

Gunduz, Seyda ^{[4
]}

Goksu, Sema Sezgin ^{[5
]}

Korkmaz, Taner ^{[6
]}

Kostek, Osman ^{[7
]}

Turhal, Serdar ^{[8
]}

Paydas, Semra ^{[9
]}

Topcu, Sevgi ^{[10
]}

Cakar, Burcu ^{[2
]}

Karabulut, Bulent ^{[2
]}

Tanriverdi, Ozgur ^{[11
]}

Karaca, Burcak ^{[2
]}

Deniz, Gulhan Ipek ^{[12
]}

Alan, Ozkan ^{[13
]}

Turkoz, Fatma Paksoy ^{[14
]}

Basaran, Gul ^{[15
]}

机构：

[1] Dr AY Ankara Oncol Hosp, Dept Med Oncol, Ankara, Turkey

[2] Ege Univ, Dept Med Oncol, Izmir, Turkey

[3] Florence Nightingale Hosp, Dept Med Oncol, Istanbul, Turkey

[4] Mem Antalya Hosp, Dept Med Oncol, Antalya, Turkey

[5] Akdeniz Univ, Dept Med Oncol, Antalya, Turkey

[6] Acibadem Mehmet Ali Aydinlar Univ, Dept Med Oncol, Istanbul, Turkey

[7] Trakya Univ, Dept Med Oncol, Edirne, Turkey

[8] Anadolu Med Ctr, Dept Med Oncol, Kocaeli, Turkey

[9] Cukurova Univ, Dept Med Oncol, Adana, Turkey

[10] Ege Univ, Dept Med Oncol, Izmir, Turkey

[11] Mugla Sitki Kocman Univ, Dept Med Oncol, Mugla, Turkey

[12] Istanbul Univ, Cerrahpasa Med Fac, Dept Med Oncol, Istanbul, Turkey

[13] Tekirdag State Hosp, Dept Med Oncol, Edirne, Turkey

[14] Med Pk Goztepe Hosp, Dept Med Oncol, Istanbul, Turkey

[15] Acibadem Mehmet Ali Aydinlar Univ, Dept Med Oncol, Istanbul, Turkey

来源：

CANCER RESEARCH | 2020年 / 80卷 / 04期

关键词：

D O I：

10.1158/1538-7445.SABCS19-P5-11-19

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P5-11-19

引用

页数：3

共 50 条

[1] Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer
Lopez-Tarruella, Sara
Jerez, Yolanda
Marquez-Rodas, Ivan
Echavarria, Isabel
Martin, Miguel
FUTURE ONCOLOGY, 2017, 13 (24) : 2137 - 2149
[2] Ribociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Burris, Howard A., III
EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 201 - 213
[3] Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Lorman-Carbo, Natalia
Martinez-Saez, Olga
Fernandez-Martinez, Aranzazu
Galvan, Patricia
Chic, Nuria
Garcia-Fructuoso, Isabel
Rodriguez, Adela
Gomez-Bravo, Raquel
Schettini, Francesco
Blasco, Paula
Castillo, Oleguer
Gonzalez-Farre, Blanca
Adamo, Barbara
Vidal, Maria
Munoz, Montserrat
Perou, Charles M.
Malumbres, Marcos
Gavila, Joaquin
Pascual, Tomas
Prat, Aleix
Braso-Maristany, Fara
SCIENTIFIC REPORTS, 2024, 14 (01):
[4] Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer
Connolly, Roisin M.
Stearns, Vered
ONCOLOGY-NEW YORK, 2013, 27 (06): : 571 - +
[5] Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
Turner, Nicholas C.
Oliveira, Mafalda
Howell, Sacha J.
Dalenc, Florence
Cortes, Javier
Moreno, Henry L. Gomez
Hu, Xichun
Jhaveri, Komal
Krivorotko, Petr
Loibl, Sibylle
Morales Murillo, Serafin
Okera, Meena
Park, Yeon Hee
Sohn, Joohyuk
Toi, Masakazu
Tokunaga, Eriko
Yousef, Samih
Zhukova, Lyudmila
de Bruin, Elza C.
Grinsted, Lynda
Schiavon, Gaia
Foxley, Andrew
Rugo, Hope S.
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (22): : 2058 - 2070
[6] Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
Morita, Midori
Ooe, Asako
Ishii, Wataru
Watanabe, Akira
Matsui, Chise
Okuyama, Yuka
Kitano, Sae
Kato, Chikage
Onishi, Mie
Sakaguchi, Koichi
Naoi, Yasuto
ANTICANCER RESEARCH, 2023, 43 (06) : 2783 - 2789
[7] Everolimus in the treatment of hormone receptor-positive breast cancer
Chavez-MacGregor, Mariana
Gonzalez-Angulo, Ana Maria
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1835 - 1843
[8] Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer
Bingnan Zhang
Elisa F. Long
Breast Cancer Research and Treatment, 2019, 175 : 775 - 779
[9] Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
Dobovisek, Luka
Krstanovic, Fran
Borstnar, Simona
Debeljak, Natasa
CANCERS, 2020, 12 (03)
[10] EVEROLIMUS TREATMENT FOR HORMONE RECEPTOR-POSITIVE BREAST CANCER
不详
CANCER DISCOVERY, 2012, 2 (01) : 12 - 12

← 1 2 3 4 5 →